Mechanisms regulating neutrophil survival and cell death

被引:60
|
作者
Laura Gabelloni, Mara [1 ]
Silvina Trevani, Analia [1 ]
Sabatte, Juan [2 ]
Geffner, Jorge [2 ,3 ]
机构
[1] Acad Nacl Med Buenos Aires, Inst Med Expt IMEX, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Fac Med, Inst Invest Med Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Hosp Clin Jose de San Martin, Inst Inmunol Genet & Metab, Buenos Aires, DF, Argentina
关键词
Neutrophils; Apoptosis; Caspases; Bcl-2; family; ROS; NETosis; COLONY-STIMULATING FACTOR; NF-KAPPA-B; BCL-2; FAMILY-MEMBERS; IMMUNE-SYSTEM; PHOSPHATIDYLINOSITOL; 3-KINASE; EXTRACELLULAR TRAPS; BH3-ONLY PROTEINS; MCL-1; EXPRESSION; FAS LIGAND; LIFE-SPAN;
D O I
10.1007/s00281-013-0364-x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neutrophils not only play a critical role as a first line of defense against bacteria and fungi infections but also contribute to tissue injury associated with autoimmune and inflammatory diseases. Neutrophils are rapidly and massively recruited from the circulation into injured tissues displaying an impressive arsenal of toxic weapons. Although effective in their ability to kill pathogens, these weapons were equally effective to induce tissue damage. Therefore, the inflammatory activity of neutrophils must be regulated with exquisite precision and timing, a task mainly achieved through a complex network of mechanisms, which regulate neutrophil survival. Neutrophils have the shortest lifespan among leukocytes and usually die via apoptosis although new forms of cell death have been characterized over the last few years. The lifespan of neutrophils can be dramatically modulated by a large variety of agents such as cytokines, pathogens, danger-associated molecular patterns as well as by pharmacological manipulation. Recent findings shed light about the complex mechanisms responsible for the regulation of neutrophil survival in different physiological, pathological, and pharmacological scenarios. Here, we provide an updated review on the current knowledge and new findings in this field and discuss novel strategies that could be used to drive the resolution of neutrophil-mediated inflammatory diseases.
引用
收藏
页码:423 / 437
页数:15
相关论文
共 50 条
  • [1] Mechanisms regulating neutrophil survival and cell death
    María Laura Gabelloni
    Analía Silvina Trevani
    Juan Sabatté
    Jorge Geffner
    Seminars in Immunopathology, 2013, 35 : 423 - 437
  • [2] New insights into the mechanisms controlling neutrophil survival
    Cabrini, Mercedes
    Nahmod, Karen
    Geffner, Jorge
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (01) : 31 - 35
  • [3] The Molecular Mechanisms of Glucocorticoids-Mediated Neutrophil Survival
    Saffar, Arash S.
    Ashdown, Heather
    Gounni, Abdelilah S.
    CURRENT DRUG TARGETS, 2011, 12 (04) : 556 - 562
  • [4] Cell Death and Survival Mechanisms in Cholangiocarcinogenesis
    D'Artista, Luana
    Seehawer, Marco
    AMERICAN JOURNAL OF PATHOLOGY, 2025, 195 (03) : 470 - 479
  • [5] Intracellular mechanisms regulating cell survival in ovarian follicles
    Johnson, AL
    ANIMAL REPRODUCTION SCIENCE, 2003, 78 (3-4) : 185 - 201
  • [6] Regulating cell death at, on, and in membranes
    Chi, Xiaoke
    Kale, Justin
    Leber, Brian
    Andrews, David W.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2014, 1843 (09): : 2100 - 2113
  • [7] Regulation of nuclear envelope permeability in cell death and survival
    Strasser, Christine
    Grote, Patricia
    Schaeuble, Karin
    Ganz, Magdalena
    Ferrando-May, Elisa
    NUCLEUS, 2012, 3 (06) : 540 - 551
  • [8] Surveying the landscape of emerging and understudied cell death mechanisms
    Leak, Logan
    Dixon, Scott J.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2023, 1870 (03):
  • [9] Mechanisms of programmed cell death of effector T lymphocytes
    Przybylski, Grzegorz
    Wielikdzien, Joanna
    Kopinski, Piotr
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2013, 67 : 1374 - 1390
  • [10] Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic
    Czystowska, Malgorzata
    Szczepanski, Miroslaw J.
    Szajnik, Marta
    Quadrini, Karen
    Brandwein, Harvey
    Hadden, John W.
    Whiteside, Theresa L.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (04) : 495 - 506